Blood News and Research

RSS

Mysteries of the hibernating heart

Hibernating, it turns out, is much more complicated than one might think.

8 Feb 2011

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

A low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns, has been developed by a group of scientists from the Hebrew University of Jerusalem, Harvard Medical School and others in the U.S. and Japan.

8 Feb 2011

How cocoa in chocolate reduces risk of heart disease

In time for the chocolate-giving and chocolate-noshing fest on Valentine's Day, scientists are reporting discovery of how this treat boosts the body's production of high-density lipoprotein cholesterol (HDL) - the "good" form of cholesterol that protects against heart disease.

8 Feb 2011

Survey finds most hospitals, birthing centers do not routinely screen for congenital heart defects

Only about two out of every 100 babies (1.8 percent) were screened at birth for congenital heart defects (CHDs) because the hospital or birthing center where the baby was born routinely screens all newborns for CHDs -- the number-one birth defect and leading killer of infants and newborns. This is according to a survey just released by Little Hearts, Inc., a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.

8 Feb 2011

Abbott's Ibis, PLEX-ID technologies identify causative organism of plague in Afghanistan

Today, at the American Society for Microbiology Conference on Biodefense and Emerging Diseases, scientists from Abbott Molecular presented data showing the unique power of the company's Ibis technology to identify and further characterize unknown disease-causing pathogens to help aid in the bioforensic analysis of pandemic outbreaks.

8 Feb 2011

Lifestyle, rather than hereditary factors, plays major role in life expectancy

How long your parents lived does not affect how long you will live. Instead it is how you live your life that determines how old you will get, reveals research from the University of Gothenburg recently published in the Journal of Internal Medicine.

8 Feb 2011

Hematopoietic stem cells are less fixed, more flexible than previously thought: Study

The bone marrow stem cells responsible for generating new blood cells are less fixed and more flexible than previously thought, according to a paper published online on February 7 in the Journal of Experimental Medicine.

8 Feb 2011

NCI awards grant to reduce cancer-related health disparities among Latinos

A $4 million, five-year grant from the National Cancer Institute will create a Texas regional Community Networks Program Center, called Latinos Contra El Cancer, to reduce cancer-related health disparities among Texas Latinos.

8 Feb 2011

Higher vitamin D levels and sun exposure linked to lower risk of multiple sclerosis

People who spend more time in the sun and those with higher vitamin D levels may be less likely to develop multiple sclerosis (MS), according to a study published in the February 8, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology. MS is a chronic disease of the brain and spinal cord, usually with recurrent flare-ups of symptoms. It is often preceded by a first episode (or event) of similar symptoms lasting days to weeks.

8 Feb 2011

Transition reports second quarter 2011 net income of $24.28M vs. $6.05M net loss for second quarter 2010

Transition Therapeutics Inc., a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets, today announced its financial results for the quarter ended December 31, 2010.

8 Feb 2011

Breakthrough in Thermal Gradient's fast PCR technology for molecular diagnostics

Thermal Gradient, a Rochester, NY biotech company, announces a breakthrough in its fast PCR technology for molecular diagnostics. PCR is the preferred critical step in virtually all forms of DNA testing.

8 Feb 2011

Munich research team provides promising alternative to DNA-based procedures

Defects in the genome are the cause of many diseases. Gene therapy - direct replacement of mutant genes by intact DNA copies - offers a means of correcting such defects. Now a research team based at the Medical Center of the University of Munich, and led by Privatdozent Dr. Carsten Rudolph, has taken a new approach that avoids DNA delivery.

8 Feb 2011

Immune system genes linked to personality traits, mental illness and suicidal behaviour

Genes linked to the immune system can affect healthy people's personality traits as well as the risk of developing mental illness and suicidal behaviour, reveals a thesis from the University of Gothenburg, Sweden.

8 Feb 2011

Abbott launches PLEX-ID Biothreat Assay to detect, distinguish 17 different pathogens

Abbott announced today that it has introduced the PLEX-ID Biothreat Assay, which is designed to detect and distinguish 17 different biothreat pathogens.

7 Feb 2011

Obesity rates double worldwide

The latest research has shown that obesity is on the rise worldwide and has actually doubled since 1980. On the other hand people in the developed countries have also managed to reduce their blood pressure and cholesterol levels. This comes from three new studies published online Feb. 3 in The Lancet.

7 Feb 2011

Gastric bypass surgery good for the heart in obese: Study

A new study has found that gastric bypass surgery, besides enabling severely obese people to lose weight, may also help their overly stressed hearts return to more normal function and appearance. The study appeared in the Feb. 8 issue of the Journal of the American College of Cardiology.

7 Feb 2011

Mothballs may cause brain damage in babies: Experts

Pediatricians have called for a ban on the sale of mothballs containing the chemical naphthalene citing evidence that these can lead to severe blood problems and even brain damage for significant numbers of Australian babies.

7 Feb 2011

Ornim receives FDA 510(k) clearance for non-invasive monitoring of blood flow in tissue

Ornim, Inc. is pleased to announce the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CerOx 3210F monitor. Additionally to its previous clearance for non-invasive monitoring of regional hemoglobin oxygen saturation in the brain or skeletal muscle, the CerOx 3210F is now also intended for use as a non-invasive monitor of blood flow in tissue of adults.

7 Feb 2011

XDx and LabCorp enter non-hospital provider agreement for AlloMap molecular expression tests

XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests to monitor immune-mediated conditions, today announced that it has entered into a multi-year agreement with Laboratory Corporation of America Holdings to provide heart transplant patients eligible for XDx's AlloMap® test with the convenience of having their blood drawn at participating LabCorp sites across the United States.

7 Feb 2011

CMD co-founder receives Prize4Life award for discovery of new ALS biomarker

Convergence Medical Devices (CMD) today announced that its co-founder, Dr. Seward Rutkove, Chief of the Division of Neuromuscular Disease at Beth Israel Deaconess Medical Center and Associate Professor of Neurology at Harvard Medical School, received Prize4Life's prestigious award for the discovery of a new biomarker for ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's disease.

7 Feb 2011

Blood News and Research

Mysteries of the hibernating heart

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

How cocoa in chocolate reduces risk of heart disease

Survey finds most hospitals, birthing centers do not routinely screen for congenital heart defects

Abbott's Ibis, PLEX-ID technologies identify causative organism of plague in Afghanistan

Lifestyle, rather than hereditary factors, plays major role in life expectancy

Hematopoietic stem cells are less fixed, more flexible than previously thought: Study

NCI awards grant to reduce cancer-related health disparities among Latinos

Higher vitamin D levels and sun exposure linked to lower risk of multiple sclerosis

Transition reports second quarter 2011 net income of $24.28M vs. $6.05M net loss for second quarter 2010

Breakthrough in Thermal Gradient's fast PCR technology for molecular diagnostics

Munich research team provides promising alternative to DNA-based procedures

Immune system genes linked to personality traits, mental illness and suicidal behaviour

Abbott launches PLEX-ID Biothreat Assay to detect, distinguish 17 different pathogens

Obesity rates double worldwide

Gastric bypass surgery good for the heart in obese: Study

Mothballs may cause brain damage in babies: Experts

Ornim receives FDA 510(k) clearance for non-invasive monitoring of blood flow in tissue

XDx and LabCorp enter non-hospital provider agreement for AlloMap molecular expression tests

CMD co-founder receives Prize4Life award for discovery of new ALS biomarker

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News